Peter A. Mulders
Nijmegen, GE 6525GA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications
Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles.
Journal: Frontiers in immunology
Published: May 05, 2026
Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 02, 2026
Response to 'Letters to the Editor' comments on the paper 'Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy'.
Journal: BJU international
Published: March 18, 2026
From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Journal: Drugs - real world outcomes
Published: March 10, 2026
Crisis readiness for rare disease populations: learnings and recommendations by the European Reference Networks.
Journal: The Lancet regional health. Europe
Published: February 25, 2026
Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy.
Journal: BJU international
Published: January 13, 2026
Impact of Heterogeneous DNA Methylation on the Accuracy of Quantitative Methylation-Specific PCR for Detecting DNA Hypermethylation in Prostate Cancer.
Journal: International journal of molecular sciences
Published: December 29, 2025
European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025.
Journal: Orphanet journal of rare diseases
Published: December 03, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 23, 2025
Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis.
Journal: European urology focus
Published: June 25, 2025
Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal: Clinical genitourinary cancer
Published: December 03, 2024
The impact of the new WHO classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 13, 2024
Last Updated: 09/26/2026